Emerging Therapies for Radioactive Iodine Refractory Thyroid Cancer
Sign Up to like & getrecommendations! Published in 2020 at "Current Treatment Options in Oncology"
DOI: 10.1007/s11864-020-0714-6
Abstract: The landscape of treatment options for radioactive iodine refractory thyroid cancer is rapidly changing. While there are no curative options in this setting, tyrosine kinase inhibitors (TKIs) have revolutionized the management of radioiodine refractory disease… read more here.
Keywords: radioactive iodine; thyroid cancer; refractory thyroid; refractory ... See more keywords
Sorafenib and Lenvatinib Treatment for Metastasis/Recurrence of Radioactive Iodine-refractory Differentiated Thyroid Carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "In Vivo"
DOI: 10.21873/invivo.12350
Abstract: Background/Aim: Radioactive iodine-refractory differentiated thyroid carcinoma (RR-DTC) has been treated with multi-kinase inhibitors (MKIs), e.g., sorafenib (SOR) and lenvatinib (LEN). We analyzed the outcomes of RR-DTC patients who underwent SOR or LEN treatment at Kuma… read more here.
Keywords: radioactive iodine; refractory differentiated; treatment; differentiated thyroid ... See more keywords
Using 18F-FDG-PET/CT Metrics to Predict Survival in Ra-Dio-Iodine Refractory Thyroid Cancers
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12102381
Abstract: Radio-iodine refractory (RAI-R) differentiated thyroid cancer (DTC) is a rare disease with a poor prognosis and limited therapeutic resources. Therefore, identifying prognostic factors is essential in order to select patients who could benefit from an… read more here.
Keywords: year; iodine refractory; fdg pet; analysis ... See more keywords
Prognostic value of serum stimulating thyroglobulin in metastatic radioactive iodine refractory differentiated thyroid cancer
Sign Up to like & getrecommendations! Published in 2023 at "Tropical Journal of Pharmaceutical Research"
DOI: 10.4314/tjpr.v22i3.27
Abstract: Purpose: To investigate the prognostic value of serum-stimulated thyroglobulin (ps-Tg) before the first 131I therapy in patients with metastatic radioactive iodine-refractory differentiated thyroid cancer (RR-DTC). Methods: From August 2017 to August 2020, the clinical data… read more here.
Keywords: thyroid cancer; cancer; dtc; iodine refractory ... See more keywords